The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy
- 1 August 2002
- journal article
- review article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 104 (1) , 3-13
- https://doi.org/10.1016/s0301-2115(02)00239-7
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: Tolerance of a new recombinant hirudinJournal of the American Academy of Dermatology, 2000
- Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodiumThe Journal of Maternal-Fetal Medicine, 2000
- Adverse Skin Reactions to Low Molecular Weight HeparinsDrug Safety, 1999
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Placental pathologic features of preterm preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995
- Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic featuresAmerican Journal of Obstetrics and Gynecology, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Thromboembolic prophylaxis with low molecular weight heparin during pregnancyInternational Journal of Gynecology & Obstetrics, 1994
- Fetal and neonatal outcome of exposure to anticoagulants during pregnancyAmerican Journal of Medical Genetics, 1993
- The Gasping Syndrome and Benzyl Alcohol PoisoningNew England Journal of Medicine, 1982